We are live on
!
Find out more
AGM
Alpine Global Management Portfolio holdings
AUM
$615M
1-Year Est. Return
34.28%
This Fund
S&P 500
This Quarter
Est. Return
+30.8%
1 Year Est. Return
+34.28%
3 Year Est. Return
+148.67%
5 Year Est. Return
+161.73%
10 Year Est. Return
+891.97%
AUM
$615M
AUM Growth
-$52.6M
(-7.9%)
Cap. Flow
-$5.73M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
62.88%
Holding
367
New
155
Increased
30
Reduced
63
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XOVR
EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF
XOVR
|
+$47.8M |
| 2 |
SPCX
SpaceX
SPCX
|
+$43.2M |
| 3 |
Bloom Energy
BE
|
+$33.6M |
| 4 |
Credo Technology Group
CRDO
|
+$26.8M |
| 5 |
Warner Bros
WBD
|
+$8.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Immunovant
IMVT
|
+$38.4M |
| 2 |
KKR & Co
KKR
|
+$15M |
| 3 |
Blue Owl Capital
OWL
|
+$14.8M |
| 4 |
Apollo Global Management
APO
|
+$14.7M |
| 5 |
Ares Management
ARES
|
+$14.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.03% |
| 2 | Industrials | 21.92% |
| 3 | Technology | 12.25% |
| 4 | Healthcare | 11.36% |
| 5 | Consumer Discretionary | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCIX
51
DELISTED
Churchill Capital Corp IX
CCIX
| $1.63M | 0.27% |
+150,000
| New | +$1.62M |
|
52
Apple
AAPL
$4.61T
| $1.61M | 0.26% |
+5,581
| New | +$1.6M |
|
53
VanEck Semiconductor ETF
SMH
$70.3B
| $1.61M | 0.26% |
2,450
-647
| -21% | -$353K |
|
54
Nokia
NOK
$59.8B
| $1.55M | 0.25% |
+116,439
| New | +$1.5M |
|
55
ExxonMobil
XOM
$659B
| $1.5M | 0.24% |
+11,002
| New | +$1.65M |
|
56
Meta Platforms (Facebook)
META
$1.57T
| $1.45M | 0.24% |
2,583
+1,085
| +72% | +$663K |
|
57
Golub Capital BDC
GBDC
$3.34B
| $1.41M | 0.23% |
109,216
-37,637
| -26% | -$490K |
|
|
OTF
58
Blue Owl Technology Finance Corp
OTF
$5.11B
| $1.34M | 0.22% |
129,027
-49,665
| -28% | -$552K |
|
59
Microsoft
MSFT
$3.67T
| $1.32M | 0.21% |
3,528
-17,031
| -83% | -$6.89M |
|
|
JBS
60
JBS N.V.
JBS
$42.6B
| $1.21M | 0.2% |
+102,000
| New | +$1.49M |
|
|
MAGN
61
Magnera Corp
MAGN
$441M
| $1.18M | 0.19% |
100,000
| – | – |
|
62
Honeywell
HON
$65.9B
| $1.12M | 0.18% |
+5,000
| New | +$1.12M |
|
|
HONA
63
Honeywell Aerospace
HONA
$49.8B
| $1.11M | 0.18% |
+5,000
| New | +$1.1M |
|
|
NFBK
64
DELISTED
Northfield Bancorp
NFBK
| $1.1M | 0.18% |
75,000
-75,000
| -50% | -$1.06M |
|
65
Amcor
AMCR
$20.8B
| $1.08M | 0.18% |
25,000
| – | – |
|
66
MGM Resorts International
MGM
$10.3B
| $1.08M | 0.17% |
+22,500
| New | +$935K |
|
67
Chevron
CVX
$415B
| $1.07M | 0.17% |
+6,466
| New | +$1.2M |
|
|
CEPF
68
Cantor Equity Partners IV
CEPF
$597M
| $1.04M | 0.17% |
100,000
| – | – |
|
|
CEPV
69
Cantor Equity Partners V
CEPV
$329M
| $1.03M | 0.17% |
100,000
-50,000
| -33% | -$512K |
|
|
GLV
70
Clough Global Dividend & Income Fund
GLV
$75.2M
| $978K | 0.16% |
147,364
-25,459
| -15% | -$159K |
|
71
CION Investment
CION
$360M
| $970K | 0.16% |
155,635
-38,425
| -20% | -$269K |
|
72
United Therapeutics
UTHR
$21.4B
| $909K | 0.15% |
+1,678
| New | +$945K |
|
73
Boston Scientific
BSX
$67.3B
| $903K | 0.15% |
+21,159
| New | +$1.15M |
|
74
Crescent Capital BDC
CCAP
$382M
| $901K | 0.15% |
82,521
-46,791
| -36% | -$571K |
|
75
ZIM Integrated Shipping Services
ZIM
$3.57B
| $887K | 0.14% |
+34,100
| New | +$880K |
|
Similar funds
BFFIM
TF
OL
FSA
IDA
AA
ATFA
CSIA
Alpine Global Management's Q2 2026 Portfolio in Review
As of Q2 2026, Alpine Global Management held 367 positions worth $615M, down 7.9% from $668M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Alpine Global Management's Q2 2026 filing shows 155 new, 30 increased, 63 reduced and 92 closed positions. Its largest new stake was EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF: 2,500,100 shares worth $52.6M. The largest sale was Immunovant, an estimated $38.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 30% a quarter earlier, followed by Industrials and Technology.
- Alpine Global Management's largest Q2 2026 buy was EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF: 2,500,100 shares worth $52.6M.
- Alpine Global Management added most to Warner Bros in Q2 2026, an estimated $8.32M increase.
- Alpine Global Management's biggest Q2 2026 reduction was Immunovant, cutting an estimated $38.4M.
- Alpine Global Management fully exited KKR & Co in Q2 2026, selling an estimated $15M.
- Alpine Global Management's ten largest holdings make up 63% of its $615M portfolio in Q2 2026.
- Alpine Global Management opened 155 new positions and closed 92 in Q2 2026.
- Alpine Global Management's portfolio value fell 7.9% quarter-over-quarter to $615M.
Based on Alpine Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.